Skip to content

Novavax

US · NVAX #2865 by market cap Listed 1970
7.47 -0.25 -3.24%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:01

✦ Quant Ownership Signal how this is computed

Distributing
  • The number of reporting institutions decreased by 6 in the most recent period (2026/Q3).
  • Total institutional ownership fell 3.1 percentage points.

Ownership vs. money flow

Aligned

Institutions trimmed shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two line up.

Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.

Institutional ownership

Held by institutions
68.45% -3.05pp
Institutions
304 -6
As of
2026/Q3 vs. prior period

Holder types

Mutual Fund38.67%
Hedge Fund19.09%
Public Company8.92%
Private Company0.88%
Individual/Insider0.79%
Government Pension Fund0.36%
Corporate Pension Plan0.24%
Insurance Company0.21%
Other30.76%

Top holders as of 2026-09-30

BlackRock 9.45% · 15.59M sh
Shah Capital Management, Inc 6.39% · 10.54M sh
State Street Global Advisors 5.35% · 8.83M sh
Vanguard Portfolio Management, LLC 4.39% · 7.25M sh
Vanguard Capital Management, LLC 4.38% · 7.23M sh
Sanofi 4.17% · 6.88M sh
D. E. Shaw & Co., L.P. 3.42% · 5.65M sh
Geode Capital Management, LLC 2.56% · 4.23M sh
Two Sigma Investments, LP 2.48% · 4.09M sh
Coatue Management 2.33% · 3.84M sh

Bar length is relative to the largest holder shown here, not to 100% of the company.

Insiders

50 filings tracked · 41 buys · 6 sells

NameRoleStake
John Jacobs Chief Executive Officer 0.19%
Elaine O'Hara Chief Strategy Officer 0.08%
James Kelly Chief Financial Officer 0.08%
John Trizzino Former President 0.07%
Mark Casey Executive Vice President 0.05%
David Mott Chairperson 0.05%
Richard Douglas Independent Director 0.04%
Gregg Alton Independent Director 0.03%
Richard Rodgers Independent Director 0.03%
Margaret McGlynn Independent Vice Chairman of the Board of Directors 0.03%

Insider transactions most recent Form 4 filings

DateNameRoleTypeSharesPrice
2026-06-19 David Mott Chairperson Derivative Exercise and Retained +18,880 --
2026-06-19 Richard Douglas Independent Director Derivative Exercise and Retained +18,880 --
2026-06-19 Margaret McGlynn Independent Vice Chairman of the Board of Directors Derivative Exercise and Retained +18,880 --
2026-06-19 Gregg Alton Independent Director Derivative Exercise and Retained +18,880 --
2026-06-19 Rachel King Independent Director Derivative Exercise and Retained +18,880 --
2026-06-19 Richard Rodgers Independent Director Derivative Exercise and Retained +18,880 --
2026-06-17 David Mott Chairperson Other Derivative Acquisition +14,180 --
2026-06-17 David Mott Chairperson Other Derivative Acquisition +21,270 $9.13
2026-06-17 Richard Douglas Independent Director Other Derivative Acquisition +14,180 --
2026-06-17 Richard Douglas Independent Director Other Derivative Acquisition +21,270 $9.13
2026-06-17 Margaret McGlynn Independent Vice Chairman of the Board of Directors Other Derivative Acquisition +14,180 --
2026-06-17 Margaret McGlynn Independent Vice Chairman of the Board of Directors Other Derivative Acquisition +21,270 $9.13
2026-06-17 Gregg Alton Independent Director Other Derivative Acquisition +14,180 --
2026-06-17 Gregg Alton Independent Director Other Derivative Acquisition +21,270 $9.13
2026-06-17 Rachel King Independent Director Other Derivative Acquisition +14,180 --
2026-06-17 Rachel King Independent Director Other Derivative Acquisition +21,270 $9.13
2026-06-17 Richard Rodgers Independent Director Other Derivative Acquisition +14,180 --
2026-06-17 Richard Rodgers Independent Director Other Derivative Acquisition +21,270 $9.13
2026-06-17 John Shiver Independent Director Other Derivative Acquisition +14,180 --
2026-06-17 John Shiver Independent Director Other Derivative Acquisition +21,270 $9.13

Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.

Quote time 2026-11-20 20:01:36 · For reference only, not investment advice and not tailored to your situation.

Novavax discussion 0 comments

Add a comment